|
US2019054070A1
|
|
Methods and Compositions for Regenerative Synaptogenesis
|
|
WO2017062924A1
|
|
Dosing regimens of pkc activators
|
|
WO2016183252A1
|
|
Treatment of neurodegenerative conditions using pkc activators after determining the presence of the apoe4 allele
|
|
WO2015148975A1
|
|
Compositions and methods to treat niemann-pick disease
|
|
US2016074359A1
|
|
Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory
|
|
EP3279638A1
|
|
Peripheral diagnostic methods for screening alzheimer's disease using beta amyloid and intercellular communication
|
|
WO2012006525A2
|
|
Pkc activators and anticoagulant in regimen for treating stroke
|
|
US2010021913A1
|
|
Stimulus-elicited genomic profile markers of alzheimer's disease
|
|
WO2009099563A2
|
|
Combination of a nmda receptor channel blocker and a pkc activator for treatment of alzheimer's disease
|
|
US2008004332A1
|
|
Methods for alzheimer's disease treatment and cognitive enhancement
|
|
US2008058396A1
|
|
Methods of stimulating cellular growth, synaptic remodelling and consolidation of long-term memory
|
|
US2007054890A1
|
|
Protein synthesis required for long-term memory is induced by PKC activation on days preceding associative learning
|
|
WO0193744A2
|
|
Controlling attention and memory by altering neuronal carbonic anhydrase activity
|
|
US4570613A
|
|
Method for the removal of splinters
|
